Cruijsen, M., Lübbert, M., Wijermans, P. e Huls, G. (2015). Clinical results of hypomethylating agents in AML treatment. Journal of Clinical Medicine, 4, 1–17. doi:10.3390/jcm4010001 Fisher, D. E., Ginsburg, D., Look, A. T., Lux, S. e Nathan, D. (2015). Nathan and Oski’s hematology and oncology of infancy and childhood (8 a ed.). Filadélfia, PA: Elsevier/Saunders. Hayes-Jordan, A., Green, H. L., Lin, H., Owusu-Agyemang, P., Fitzgerald, N., Arunkumar, R., . . . Anderson, P. (2014). Complete cytoreduction and HIPEC improves survival in desmoplastic small round cell tumor. Annals of Surgical Oncology, 21 (1), 220–224. doi:10.1245/ s10434-013-3269-y Lexi-Comp Online Drug Formulary. (2016). Hudson, OH: Wolters Kluwer. Micromedex 2.0, versão eletrônica. (2016). Greenwood Village, CO: Truven Health Analytics. Moriyama, B., Falade, O., Leung, J., Penzak, S. R., Jingo, C., Huang, X., . . . Walsh, T. J. (2011). Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: Avoiding a serious adverse drug interaction. Mycoses, 54 (6), e877– e879. Extraído de: http://doi.org/10.1111/j.1439-0507.2011.02016.x Muehlbauer, P. M., Shelburne, N. e Shields, S. (2014). Principles of antineoplastic therapy. Em M. Polovich, M. Olsen e K. B. LeFebvre (Eds.), Chemotherapy and biotherapy guidelines and recommendations for practice (4ª ed., pp. 25-50). Pittsburgh, PA: Oncology Nursing Society. Orkin, S. H., Fisher, D. E., Ginsburg, D., Look, A. T., Lux, S. E. e Nathan, D. G. (Eds.). (2015). Nathan and Oski’s hematology and oncology of infancy and childhood (8 a ed.). Filadélfia, PA: Elsevier/Saunders. Ruccione, K. (2011). The biological basis of cancer. Em C. Baggott, D. Fochtman, G. Foley e K. Kelly (Eds.), Nursing care of children and adolescents with cancer and blood disorders (4ª ed., pp. 36–113). Glenview, IL: Association of Pediatric Hematology/Oncology Nurses. Santini, V. (2012). Novel therapeutic strategies: Hypomethylating agents and beyond. American Society of Hematology, the Education Program, 2012, 65–73. doi:10.1182/asheducation-2012.1.65
Referências Adamson, P. C., Blaney, S. M., Bagatell, R., Skolnik, J. M. e Balis, F. M. (2016). General principles of chemotherapy. Em P. A. Pizzo e D. G. Poplack (Eds.), Principles and practice of pediatric oncology (7 a ed., pp. 239–315). Filadélfia, PA: Wolters Kluwer. Ettinger, A. G., Echtenkamp, D., Harley, J., Wills, M. S. e McNeil, S. B. (2011). Chemotherapy. Em C. Baggott, D. Fochtman, G. Foley e K. Kelly (Eds.), Nursing care of children and adolescents with cancer and blood disorders (4ª ed., pp. 326–382). Glenview, IL: Association of Pediatric Hematology/Oncology Nurses. Goldie, J. H. e Coldman, A. J. (1984). The genetic origin of drug resistance in neoplasms: Implications for systemic therapy. Cancer Research, 44 , 3643–3653. Landier, W., Hageman, L., Chen, Y., Kornegay, N., Evans, W. E., Bostrom, B. C., Casillas, J., … Bhatia, S. (2017). Mercaptopurine ingestion habits, red cell thioguanine nucleotide levels, and relapse risk in children with acute lymphoblastic leukemia: A report from the Children’s Oncology Group Study AALL03N1. Journal of Clinical Oncology, 35 (15), 1730–1736. Menonna-Quinn, D. (2014). Administration considerations. Em M. Polovich, M. Olsen e K. B. LeFebvre (Eds.), Chemotherapy and biotherapy guidelines and recommendations for practice (4ª ed., pp. 121–135). Pittsburgh, PA: Oncology Nursing Society. National Cancer Institute. (s.d.). NCI dictionary of cancer terms . Extraído de: https://www.cancer.gov/publications/dictionaries/ cancer-terms?search=dose Polovich, M., Olsen, M. e LeFebvre, K. B. (Eds.). (2014). Chemotherapy and biotherapy guidelines and recommendations for practice (4 a ed.). Pittsburgh, PA: Oncology Nursing Society. Schmidt, C. (2004). The Gompertzian view: Norton honored for role in establishing cancer treatment approach. Journal of the National Cancer Institute, 96 (20), 1492–1493. doi.org/10.1093/jnci/96.20.1492 Womer, R. B., West, D. C., Krailo, M. D., Dickman, P. S., Pawel, B. R., Grier, H. E., . . . Weiss, A. R. (2012). Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: A report from the Children’s Oncology Group. Journal of Clinical Oncology, 30 (33), 4148–4154. doi:10.1200/ JCO.2011.41.5703 Woodhouse, J. R. e Ferry, D. F. (1995). The genetic basis of resistance to cancer chemotherapy. Annals of Medicine, 27 (2), 157–167. Recursos adicionais Children’s Oncology Group. (2015). Referência sobre extravasamento. Extraído de: https://www.cogmembers.org/_files/disc/Nursing/ ExtravasationReference.pdf Children’s Oncology Group. (2016). Drug information for commercial agents used by the Children’s Oncology Group, Versão 9. Extraído de: https://www.cogmembers.org/_files/disc/Pharmacy/ CommercialAgentsMonographs_v9.pdf Children’s Oncology Group. (2016). Parenteral and oral chemotherapy administration guidelines used by the Children’s Oncology Group, Versão 8. Extraído de: https://www.cogmembers.org/_files/disc/ Pharmacy/ChemoAdminGuidelines.pdf
89
Capítulo 4. Quimioterapia: Princípios e Agentes
Powered by FlippingBook